• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

sigma-1 受体作为多巴胺神经递质的调节剂:一种潜在的治疗甲基苯丙胺成瘾的靶点。

The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

机构信息

University of Florida, College of Medicine, Department of Neuroscience, Gainesville, FL 32611, United States.

University of Florida, College of Medicine, Department of Neuroscience, Gainesville, FL 32611, United States.

出版信息

Pharmacol Ther. 2018 Jun;186:152-167. doi: 10.1016/j.pharmthera.2018.01.009. Epub 2018 Jan 31.

DOI:10.1016/j.pharmthera.2018.01.009
PMID:29360540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5962385/
Abstract

Methamphetamine (METH) abuse is a major public health issue around the world, yet there are currently no effective pharmacotherapies for the treatment of METH addiction. METH is a potent psychostimulant that increases extracellular dopamine levels by targeting the dopamine transporter (DAT) and alters neuronal activity in the reward centers of the brain. One promising therapeutic target for the treatment of METH addiction is the sigma-1 receptor (σR). The σR is an endoplasmic reticulum-localized chaperone protein that is activated by cellular stress, and, unique to this chaperone, its function can also be induced or inhibited by different ligands. Upon activation of this unique "chaperone receptor", the σR regulates a variety of cellular functions and possesses neuroprotective activity in the brain. Interestingly, a variety of σR ligands modulate dopamine neurotransmission and reduce the behavioral effects of METH in animal models of addictive behavior, suggesting that the σR may be a viable therapeutic target for the treatment of METH addiction. In this review, we provide background on METH and the σR as well as a literature review regarding the role of σRs in modulating both dopamine neurotransmission and the effects of METH. We aim to highlight the complexities of σR pharmacology and function as well as the therapeutic potential of the σR as a target for the treatment of METH addiction.

摘要

甲基苯丙胺(METH)滥用是全球范围内的一个主要公共卫生问题,但目前尚无有效的药物治疗方法来治疗 METH 成瘾。METH 是一种强效的精神兴奋剂,通过靶向多巴胺转运体(DAT)增加细胞外多巴胺水平,并改变大脑奖励中心的神经元活动。治疗 METH 成瘾的一个有前途的治疗靶点是西格玛-1 受体(σR)。σR 是一种内质网定位的伴侣蛋白,通过细胞应激激活,并且与这种伴侣蛋白不同,其功能也可以被不同的配体诱导或抑制。这种独特的“伴侣受体”激活后,σR 调节多种细胞功能,并在大脑中具有神经保护活性。有趣的是,各种 σR 配体调节多巴胺神经传递,并减少动物成瘾行为模型中 METH 的行为效应,这表明 σR 可能是治疗 METH 成瘾的一个可行的治疗靶点。在这篇综述中,我们提供了 METH 和 σR 的背景知识,以及关于 σRs 调节多巴胺神经传递和 METH 效应的文献综述。我们旨在强调 σR 药理学和功能的复杂性,以及将 σR 作为治疗 METH 成瘾的靶点的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8251/5962385/938726888d9d/nihms938594f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8251/5962385/90d710e3bc7d/nihms938594f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8251/5962385/938726888d9d/nihms938594f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8251/5962385/90d710e3bc7d/nihms938594f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8251/5962385/938726888d9d/nihms938594f2.jpg

相似文献

1
The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.sigma-1 受体作为多巴胺神经递质的调节剂:一种潜在的治疗甲基苯丙胺成瘾的靶点。
Pharmacol Ther. 2018 Jun;186:152-167. doi: 10.1016/j.pharmthera.2018.01.009. Epub 2018 Jan 31.
2
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.sigma-1 受体调节 methamphetamine 对多巴胺神经递质的失调作用。
Nat Commun. 2017 Dec 20;8(1):2228. doi: 10.1038/s41467-017-02087-x.
3
Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions.sigma-1 受体与多巴胺转运体的关联通过独特的螺旋-螺旋相互作用减弱了 methamphetamine 的结合。
Chem Biol Drug Des. 2021 Jun;97(6):1194-1209. doi: 10.1111/cbdd.13841. Epub 2021 Apr 4.
4
Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.甲基苯丙胺通过σ受体介导的途径诱导伏隔核多巴胺释放。
Neuropsychopharmacology. 2018 May;43(6):1405-1414. doi: 10.1038/npp.2017.291. Epub 2017 Nov 29.
5
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.σ-1受体调节多巴胺转运体构象和可卡因结合,从而可能增强大鼠对可卡因的自我给药行为。
J Biol Chem. 2017 Jul 7;292(27):11250-11261. doi: 10.1074/jbc.M116.774075. Epub 2017 May 11.
6
CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.CM156,一种高亲和力的西格玛配体,可减弱安非他命对小鼠的兴奋和神经毒性作用。
Neuropharmacology. 2011 Oct-Nov;61(5-6):992-1000. doi: 10.1016/j.neuropharm.2011.06.028. Epub 2011 Jul 7.
7
Could sigma receptor ligands be a treatment for methamphetamine addiction?σ受体配体能否成为治疗甲基苯丙胺成瘾的方法?
Curr Drug Abuse Rev. 2010 Sep;3(3):156-62. doi: 10.2174/1874473711003030156.
8
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.癸酸GBR12909作为治疗甲基苯丙胺成瘾长效药物的临床前评估
Ann N Y Acad Sci. 2002 Jun;965:92-108. doi: 10.1111/j.1749-6632.2002.tb04154.x.
9
Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.通过σ受体拮抗作用减轻甲基苯丙胺诱导的效应:来自体内和体外研究的证据。
Eur Neuropsychopharmacol. 2008 Dec;18(12):871-81. doi: 10.1016/j.euroneuro.2008.07.006. Epub 2008 Aug 27.
10
The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.西格玛受体配体(±)-BMY 14802通过与多巴胺受体相互作用预防甲基苯丙胺诱导的多巴胺能神经毒性。
J Pharmacol Exp Ther. 1994 Apr;269(1):44-50.

引用本文的文献

1
Amphetamine-type stimulant (ATS) use and association with concurrent use of benzodiazepines, barbiturates and THC in the West Bank among male Palestinians: a cross-sectional study.约旦河西岸巴勒斯坦男性中苯丙胺类兴奋剂(ATS)的使用及其与同时使用苯二氮卓类、巴比妥类药物和四氢大麻酚的关联:一项横断面研究。
BMJ Public Health. 2023 Dec 22;1(1):e000537. doi: 10.1136/bmjph-2023-000537. eCollection 2023 Nov.
2
Mechanisms and treatments of methamphetamine and HIV-1 co-induced neurotoxicity: a systematic review. methamphetamine 和 HIV-1 共致神经毒性的机制和治疗方法:系统综述。
Front Immunol. 2024 Aug 19;15:1423263. doi: 10.3389/fimmu.2024.1423263. eCollection 2024.
3
Single-cell RNA-seq Reveals the Inhibitory Effect of Methamphetamine on Liver Immunity with the Involvement of Dopamine Receptor D1.单细胞RNA测序揭示了甲基苯丙胺通过多巴胺受体D1对肝脏免疫的抑制作用。
Genomics Proteomics Bioinformatics. 2024 Oct 15;22(4). doi: 10.1093/gpbjnl/qzae060.
4
Psychomotor Symptoms, Cognitive Impairments, and Suicidal Thoughts after COVID-19 Infection: A Case Report and Possible Allostatic Mechanism.新冠病毒感染后的精神运动症状、认知障碍及自杀念头:一例报告及可能的非稳态机制
Ann Geriatr Med Res. 2024 Sep;28(3):370-374. doi: 10.4235/agmr.24.0037. Epub 2024 May 17.
5
Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learning.利用可解释的机器学习分析新生儿脑炎症增强成年大鼠中甲基苯丙胺诱导的复发性行为敏感化。
Neurochem Int. 2024 Jun;176:105743. doi: 10.1016/j.neuint.2024.105743. Epub 2024 Apr 17.
6
Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats.双重 DAT 和 sigma 受体抑制剂可减弱可卡因对大鼠伏隔核多巴胺动力学的影响。
Eur J Neurosci. 2024 May;59(10):2436-2449. doi: 10.1111/ejn.16293. Epub 2024 Mar 5.
7
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review.迷幻药和二甲色胺不良事件和毒性分析:系统主题回顾。
Int J Toxicol. 2024 May-Jun;43(3):327-339. doi: 10.1177/10915818241230916. Epub 2024 Feb 16.
8
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics.sigma 受体配体可预防 COVID 患者死亡:对未来治疗的启示。
Int J Mol Sci. 2023 Oct 29;24(21):15718. doi: 10.3390/ijms242115718.
9
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases.神经递质对神经退行性疾病神经生物学的影响。
Int J Mol Sci. 2023 Oct 19;24(20):15340. doi: 10.3390/ijms242015340.
10
Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking.针对σ1受体系统的药物研发新进展:对旨在减少过度药物和食物寻求行为的新型药物的启示
Addict Neurosci. 2023 Dec;8. doi: 10.1016/j.addicn.2023.100126. Epub 2023 Aug 27.

本文引用的文献

1
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.sigma-1 受体调节 methamphetamine 对多巴胺神经递质的失调作用。
Nat Commun. 2017 Dec 20;8(1):2228. doi: 10.1038/s41467-017-02087-x.
2
Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel.σ受体配体通过抑制Kv2.1通道的潜在独立作用。
Oncotarget. 2017 Jul 26;8(35):59345-59358. doi: 10.18632/oncotarget.19581. eCollection 2017 Aug 29.
3
Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.σ-1受体基因敲除会增加α-突触核蛋白的聚集和磷酸化,并导致黑质中多巴胺能神经元的丧失。
Neurobiol Aging. 2017 Nov;59:171-183. doi: 10.1016/j.neurobiolaging.2017.08.007. Epub 2017 Aug 10.
4
Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.Sigma 2 受体/Tmem97 激动剂在小鼠中产生持久的抗神经病理性疼痛作用。
ACS Chem Neurosci. 2017 Aug 16;8(8):1801-1811. doi: 10.1021/acschemneuro.7b00200. Epub 2017 Jul 13.
5
Identification of the gene that codes for the σ receptor.鉴定编码 σ 受体的基因。
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7160-7165. doi: 10.1073/pnas.1705154114. Epub 2017 May 30.
6
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.σ-1受体调节多巴胺转运体构象和可卡因结合,从而可能增强大鼠对可卡因的自我给药行为。
J Biol Chem. 2017 Jul 7;292(27):11250-11261. doi: 10.1074/jbc.M116.774075. Epub 2017 May 11.
7
N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice.N-苯基丙基-N'-取代哌嗪占据σ受体并改变小鼠中甲基苯丙胺诱导的多动。
Pharmacol Biochem Behav. 2016 Nov-Dec;150-151:198-206. doi: 10.1016/j.pbb.2016.11.003. Epub 2016 Nov 13.
8
Methamphetamine Regulation of Firing Activity of Dopamine Neurons.甲基苯丙胺对多巴胺能神经元放电活动的调节
J Neurosci. 2016 Oct 5;36(40):10376-10391. doi: 10.1523/JNEUROSCI.1392-16.2016.
9
Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.脑多巴胺神经元“损伤”:甲基苯丙胺使用者与帕金森病——证据的批判性评估
Eur J Neurosci. 2017 Jan;45(1):58-66. doi: 10.1111/ejn.13363. Epub 2016 Sep 5.
10
Aberrant Subcellular Dynamics of Sigma-1 Receptor Mutants Underlying Neuromuscular Diseases.神经肌肉疾病潜在的西格玛-1受体突变体的异常亚细胞动力学
Mol Pharmacol. 2016 Sep;90(3):238-53. doi: 10.1124/mol.116.104018. Epub 2016 Jul 14.